Diabetic Macular Edema
An Introduction to Diabetic Macular Oedema
The introduction of anti-vascular endothelial growth factor (anti-VEGF) therapies changed the standard of care for patients with diabetic macular oedema, however, the need for longer-acting medications and novel therapeutic targets still exist. Looking to the future, new treatments targeting multiple pathways are currently under investigation.
Browse the content below, to see leading experts discuss the latest data in video interviews and short articles from our conference hub. You can also view the selection of peer-reviewed articles from our journals. If you’re looking to learn more about the impact of these developments on patient outcomes, our educational activities are a great resource.
Our supporting partners do not constitute an endorsement of the content on this page.
This week in ophthalmology: a new ranibizumab biosimilar approval, smartphone-based artificial intelligence (AI) for ocular surface malignancy detection, an update on corneal allogenic intrastromal ring segments in keratoconus, diabetic eye disease data from ADA 2026 and FDA designations for a potential neurotrophic keratitis therapy. Here are five stories to catch up on this week.
New data presented at ADA 2026 explored diabetic retinopathy risk, incretin therapy safety, AI-based screening, real-world DME outcomes and a potential new oral approach to retinal vascular disease.
At the ARVO 2026 Annual Meeting, DME remained a major focus, with multiple studies exploring how clinicians may extend treatment intervals, improve outcomes in suboptimal responders and target inflammatory pathways beyond VEGF. Across phase 2 and phase 3 trials, as well as real-world observational studies, key themes included long-term durability with faricimab, sustained-delivery approaches, and growing evidence supporting dual-pathway strategies that may help address the heterogeneity of DME in routine practice.
In this expert Q&A, Dr Marina Roizenblatt shares a global and developing-world perspective on rapidly progressing DR, drawing on her clinical experience in Brazil to explore how biological risk factors, health system limitations and pragmatic treatment approaches intersect in real-world practice.
2025 has brought a wave of innovation and developments that are already reshaping day-to-day clinical practice. We asked our key faculty to reflect on what they believe has been most impactful so far this year – here’s what they told us.
Artificial intelligence (AI) is becoming an increasingly important cornerstone of innovation in ophthalmology. From diagnostics and treatment planning to practice management and clinical research, its potential to impact patient care is immense. We asked five leading experts in the field what excites them most about AI in their daily practice and future applications.Â
In this Voices in vision Q&A, Dr Arrigo discusses the current clinical challenges facing retinal specialists, the developments that have shaped practice over the past year, and how artificial intelligence could transform diagnosis and patient management in the years ahead.
In this Q&A, Dr Cicinelli reflects on the growing challenge of managing eye care in an aging population and the opportunities this brings for innovation.
In this episode of Visionary Voices, we welcome Associate Professor Grace Vincent from CQUniversity’s Appleton Institute. A leading expert on sleep and shift work, Grace explores how disrupted sleep affects physician health in both the short and long term, as well as its impact on safety and performance. We also discuss what this means for patient outcomes and share practical strategies to manage sleep loss.
With the second half of 2025 underway, we asked our  touchOPHTHALMOLOGY Future Leaders 2025 to share the developments they believe will shape the future of the field. Here, they highlight four exciting areas that look set to change practice - not only as the year draws to a close, but well into the future.
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career clinicians ready to think beyond the bedside and explore the business of medicine.
Taking place from 7–9 June 2025 in Lisbon, Portugal, the SOE Congress is one of Europe's leading multi-specialty ophthalmology meetings. With a world-class scientific programme, this in-person event offers a rich mix of symposia, live surgery, debates, workshops, mystery cases and updates ...
In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
